+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hemostats Market to 2027 - Global Analysis and Forecasts by Product; End User; and Geography

  • ID: 5006384
  • Report
  • February 2020
  • Region: Global
  • 145 Pages
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • B. Braun Melsungen Ag
  • Baxter
  • BD
  • Biom’up
  • GELITA MEDICAL
  • Pfizer, Inc.
The global hemostats market is expected to reach US$ 3,557.41 Mn in 2027 from US$ 2,206.00 Mn in 2019. The market is estimated to grow with a CAGR of 6.3% from 2020-2027.

The growth of the hemostats market is primarily attributed to the factors such as increasing number of surgical procedures, increasing cases of sports injuries and technological advancements leading to launch of new products in the market. However, lack of reimbursement for hemostatic agents is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in emerging regions are likely to have a positive impact on the growth of the global hemostats market during the forecast period.

The rise in the incidences of sports injuries is contributed by weekend sports players, professional athletes, youngsters, children playing in the societies, and sometimes adults. Most of the sports injuries are orthopedic injuries that include swelling, pain, strain, sprain, fractures, ligament breaks, and others. These injuries are broadly classified as acute and chronic types. The injuries or lesions are caused by sports such as water sports, water soccer (football), cricket, basketball, rugby, athletic games, and others. For instance, according to the Federation Internationale de Football Association (FIFA), the data has revealed that sports injuries are majorly caused by soccer. Similarly, in cricket, the bowlers are more prone to get injured from the repetitive motion of their legs, elbow, and shoulders. The typical hams and injuries that are being observed are impingement syndromes, rotator cuff tears, ankle sprains, as well as medial ligament injuries to the elbow. Therefore, averagely 10% of the cricketers may suffer from lesions at any point in time in the field and approx. 15% of the incidences are contributed by the fast bowlers. After analyzing the facts and figures provided by the different organizations, it is expected that the market for the hemostats is likely to experience favorable growth in the forecast period.

Global hemostats market, based on the product, is segmented into Standalone Systems and Integrated Systems. In 2019, the Standalone Systems held the largest share of the market, by product. Also, integrated systems segment is expected to grow at the fastest rate during the coming years owing to increasing adoption of integrated systems across the globe.

Global hemostats market, based on the product, is segmented into thrombin-based hemostats, combination hemostats, gelatin based hemostats, collagen based hemostats and oxidized regenerated cellulose based hemostats. In 2019, the thrombin-based hemostats segment held the largest share of the market, by product. Thrombin can be manufactured as recombinant thrombin that eliminates the risk of antibody development and offer various other advantages which attributes to the dominance of the segment.

Some of the major primary and secondary sources for Hemostats included in the report are Centers for Disease Control and Prevention (CDC), USFDA, Central Intelligence Agency (CIA), National Clinical Database, and others.

Reasons to Buy:
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hemostats market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global hemostats market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen Ag
  • Baxter
  • BD
  • Biom’up
  • GELITA MEDICAL
  • Pfizer, Inc.

1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Hemostats Market - By Product
1.3.2 Global Hemostats Market - By End User
1.3.3 Global Hemostats Market - By Geography
2. Global Hemostats Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Hemostats- Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 APAC: PEST Analysis
4.2.4 MEA: PEST Analysis
4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion
5. Global Hemostats Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in the Number of Surgical Procedures
5.1.2 Increasing Incidences of Sports Injuries
5.2 Key Market Restraints
5.2.1 Lack of Reimbursement
5.3 Key Market Opportunities
5.3.1 Growth in the Global Healthcare Market
5.4 Future Trends
5.4.1 Research Activities And Product Innovations
5.5 Impact Analysis
6. Hemostats Market - Global Analysis
6.1 Global Hemostats Market Revenue Forecast And Analysis
6.2 Global Hemostats Market, By Geography - Forecast And Analysis
6.3 Positioning of Key Players
7. Global Hemostats Market Analysis- by Product
7.1 Overview
7.2 Global Hemostats Market, by Product 2019 and 2027 (%)
7.3 Thrombin Based Hemostats
7.3.1 Overview
7.3.2 Thrombin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.4 Combination Hemostats
7.4.1 Overview
7.4.2 Combination Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.5 Gelatin Based Hemostats
7.5.1 Overview
7.5.2 Gelatin Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.6 Collagen Based Hemostats
7.6.1 Overview
7.6.2 Collagen Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
7.7 Oxidized Regenerated Cellulose Based Hemostats
7.7.1 Overview
7.7.2 Oxidized Regenerated Cellulose Based Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
8. Hemostats Market Analysis- by End User
8.1 Overview
8.2 Hemostats Market, by End User 2019 and 2027 (%)
8.3 Hospitals and Clinics
8.3.1 Overview
8.3.2 Hospitals and Clinics Market, Revenue and Forecast to 2027 (US$ Mn)
8.4 Ambulatory Care Centers
8.4.1 Overview
8.4.2 Ambulatory Care Centers Market, Revenue and Forecast to 2027 (US$ Mn)
8.5 Others
8.5.1 Overview
8.5.2 Others Market, Revenue and Forecast to 2027 (US$ Mn)
9. Hemostats Market - Geographic Analysis
9.1 North America Hemostats Market Revenue and Forecasts to 2027
9.1.1 North America Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.2 North America Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.3 North America Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.4 North America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.1.5 US Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.1 US Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.5.2 US Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.5.3 US Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.6 Canada Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.1 Canada Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.6.2 Canada Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.6.3 Canada Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.1.7 Mexico Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.1 Mexico Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.1.7.2 Mexico Hemostats Market Revenue and Forecasts to 2027, By Product (US$ Mn)
9.1.7.3 Mexico Hemostats Market Revenue and Forecasts to 2027, By End User (US$ Mn)
9.2 Europe Hemostats Market, Revenue and Forecast to 2027
9.2.1 Overview
9.2.2 Europe Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.3 Europe Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.4 Europe Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.5 Europe Hemostats Market, Revenue and Forecast to 2027, by Country (%)
9.2.6 Germany Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.6.1 Germany Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.6.2 Germany Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.6.3 Germany Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.7 UK Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.7.1 UK Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.7.2 UK Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.7.3 UK Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.8 France Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.8.1 France Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.8.2 France Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.8.3 France Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.9 Spain Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.9.1 Spain Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.9.2 Spain Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.9.3 Spain Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.2.10 Italy Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.2.10.1 Italy Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.2.10.2 Italy Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.2.10.3 Italy Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3 Asia Pacific Hemostats Market Revenue and Forecasts to 2027
9.3.1 Asia Pacific Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.3.2 Asia Pacific Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.3 Asia Pacific Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.1 Asia Pacific Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.3.2 Japan
9.3.2.1 Japan Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.2.2 Japan Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.3 China
9.3.3.1 China Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.3.2 China Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.3.3 China Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.4 India
9.3.4.1 India Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.4.2 India Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.4.3 India Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.5 South Korea
9.3.5.1 South Korea Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.5.2 South Korea Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.5.3 South Korea Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.3.6 Australia
9.3.6.1 Australia Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.3.6.2 Australia Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.3.6.3 Australia Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027
9.4.1 Overview
9.4.2 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.3 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.4 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.5 Middle East & Africa Hemostats Market, Revenue and Forecast to 2027, by Country (%)
9.4.6 Saudi Arabia
9.4.6.1 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.6.2 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.6.3 Saudi Arabia Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.7 UAE
9.4.7.1 UAE Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.7.2 UAE Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.7.3 UAE Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.4.8 South Africa
9.4.8.1 South Africa Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.4.8.2 South Africa Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.4.8.3 South Africa Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5 South And Central America Hemostats Market Revenue And Forecasts To 2027
9.5.1 South and Central America Hemostats Market, Revenue and Forecast to 2027 (US$ Mn)
9.5.2 South and Central America Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.3 South and Central America Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.4 South and Central America Hemostats Market Revenue and Forecasts to 2027, By Country (%)
9.5.5 Brazil
9.5.5.1 Brazil Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.5.2 Brazil Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.5.3 Brazil Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
9.5.6 Argentina
9.5.6.1 Argentina Hemostats Market Revenue and Forecasts to 2027 (US$ Mn)
9.5.6.2 Argentina Hemostats Market, Revenue and Forecast to 2027, by Product (US$ Mn)
9.5.6.3 Argentina Hemostats Market, Revenue and Forecast to 2027, by End User (US$ Mn)
10. Hemostats Market -Industry Landscape
10.1 Overview
10.2 Growth Strategies In The Hemostats Market, 2015-2019
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 BD
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 B. Braun Melsungen AG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Baxter International Inc.
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Integra Life Sciences Corporation
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Teleflex Incorporated
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Johnson & Johnson Services, Inc.
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Biom'up
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Z-Medica, LLC
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Gelita Medical
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Pfizer Inc.
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
12. Appendix
12.1 About the Publisher
12.2 Glossary of Terms
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Johnson & Johnson Services, Inc. (Ethicon LLC)
  • BD
  • Baxter
  • B. Braun Melsungen Ag
  • Pfizer, Inc.
  • GELITA MEDICAL
  • Integra Lifesciences Holdings Corporation
  • Z-Medica, LLC
  • Biom’up
  • Teleflex Incorporated
Note: Product cover images may vary from those shown